Thursday, 9 April 2026
PERSPECTA
News from every angle
All
World
Politics
Business
Technology
Finance
Science
Health
Culture
Opinion
Environment
← Back to headlines
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward
15 Mar, 09:39 — 15 Mar, 09:39
Post
Share
Copy link
Embed
Sources
Sort: Relevance
Sort: Latest
Sort: Bias (L→R)
Sort: Bias (R→L)
Sort: Factuality
left
center
right
Showing 1 of 1 sources
Yahoo
Mostly Factual
25d ago
Xenon Pharmaceuticals (XENE) Climbs 31.7% as Epilepsy Treatment Moves Forward
Read full article →
Something wrong with this story? Report an issue
Related Stories
Serbia Records Decrease in Flu Cases
22m ago
'Ketamine Queen' Jasveen Sangha Sentenced to 15 Years for Matthew Perry's Death
29m ago
Drug Dealer Sentenced for Matthew Perry's Ketamine Overdose Death
29m ago
Charlotte Murder Suspect's State Trial Stalls Amid Competency Claims, Federal Case
31m ago
Thursday, 9 April 2026
Explore
Log in
Sign up
en
PERSPECTA
News from every angle
